FDA Scientific Fairness for Women Act
Latest action · Oct 2, 2006 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedSep 28, 2006
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
FDA Scientific Fairness for Women Act - Amends the Federal Food, Drug, and Cosmetic Act to establish the Office of Women's Health within the Office of the Commissioner of the Food and Drug Administration (FDA).
Prohibits the Secretary of Health and Human Services from finding that a reasonable assurance of safety has been shown for an application for premarket approval for a class III device for a breast implant unless the applicant involved has established the lifetime of the implant and demonstrates that safety has been demonstrated for the life of the implant. Requires the Secretary to determine appropriate clinical care and removal and replacement requirements for the implant, including appropriate coverage by government health care systems.
Sets forth provisions governing any FDA advisory committee that considers issues concerning breast implants, including that the Secretary may not grant any exemption for conflicts related to personal financial interests.
Requires the Secretary to: (1) provide for a study on the ionization and levels of platinum in silicone breast implants; and (2) establish a panel of independent scientists for the purpose of designing and conducting the study.
Requires the Secretary, acting through the Commissioner of Food and Drugs, to convene a scientific workshop to review and evaluate current scientific data on the use of emergency contraception by females of childbearing potential under the age of 18, including scientific questions identified in the recent limited approval of Plan B emergency contraception.
Cosponsors 16
Members who signed on, in the order they did. Signatures ran from Sep 28, 2006 to Dec 5, 2006; 11 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Fortney Pete Stark | Original | Sep 28, 2006 |
| D-CA | Hilda L. Solis | Original | Sep 28, 2006 |
| D-VA | James P. Moran | Original | Sep 28, 2006 |
| D-WA | Jim McDermott | Original | Sep 28, 2006 |
| D-MI | John Conyers, Jr. | Original | Sep 28, 2006 |
| D-CA | Linda T. Sánchez | Original | Sep 28, 2006 |
| D-CA | Lois Capps | Original | Sep 28, 2006 |
| D-NY | Maurice D. Hinchey | Original | Sep 28, 2006 |
| D-AZ | Raúl M. Grijalva | Original | Sep 28, 2006 |
| D-TX | Sheila Jackson Lee | Original | Sep 28, 2006 |
| D-CA | Susan A. Davis | Original | Sep 28, 2006 |
| D-NY | Carolyn B. Maloney | Sep 29, 2006 | |
| D-MA | Barney Frank | Nov 13, 2006 | |
| D-IL | Janice D. Schakowsky | Dec 5, 2006 | |
| D-VA | Rick Boucher | Dec 5, 2006 | |
| D-FL | Robert Wexler | Dec 5, 2006 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Sep 28, 2006 |
| Health Subcommittee | Referred Oct 2, 2006 |
Actions 3
Everything that happened, newest first.
- Oct 2, 2006Referred to the Subcommittee on Health.
- Sep 28, 2006Introduced in House
- Sep 28, 2006Referred to the House Committee on Energy and Commerce.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the Office of Women's Health and the regulation of breast implants, and to provide for a scientific workshop on the use of emergency contraception by women under age 18.
- Short Titles as Introduced
- FDA Scientific Fairness for Women Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Child health
- Commerce
- Conflict of interests
- Congressional reporting requirements
- Consumer education
- Contraceptives
- Department of Health and Human Services
- Drugs
- Executive reorganization
- Families
- Federal advisory bodies
- Finance and Financial Sector
- Food and Drug Administration (FDA)
- Government employees' health insurance
- Government Operations and Politics
- Government publicity
- Health
- Labeling
- Medical ethics
- Medical research
- Pharmaceutical research
- Platinum
- Product safety
- Prosthesis
- Science, Technology, Communications
- Women's health
Text 1
Each version as it was printed, newest first.
- Sep 28, 2006Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.